Literature DB >> 23493657

Incorporating dynamics for predicting poor outcome in acute liver failure patients.

Robert Afm Chamuleau1, Kama A Wlodzimirow, Ameen Abu-Hanna.   

Abstract

Acute liver failure (ALF), also known as fulminant hepatic failure (FHF), is a devastating clinical syndrome with a high mortality of 60%-90%. An early and exact assessment of the severity of ALF together with prediction of its further development is critical in order to determine the further management of the patient. A number of prognostic models have been used for outcome prediction in ALF patients but they are mostly based on the variables measured at one time point, mostly at admission. ALF patients rarely show a static state: rapid progress to a life threatening situation occurs in many patients. Since ALF is a dynamic process, admission values of prognostic variables change over time during the clinical course of the patient. Kumar et al developed a prognostic model [ALF early dynamic (ALFED)] based on early changes in values of variables which predicted outcome. ALFED is a model which seems to be worthwhile to test in ALF patients in other parts of the world with different aetiologies. Since the exact pathophysiology of ALF is not fully known and is certainly complex, we believe that adding promising variables involved in the pathophysiology of ALF to the dynamic approach might even further improve prognostic performance. We agree with Kumar et al that an improved dynamic prognostic model should be based on simplicity (easily to be performed at the bedside) and accuracy. Our comments presented in this paper may be considered as recommendations for future optimization of ALF prediction models.

Entities:  

Keywords:  Acute liver failure; Fulminant hepatic failure; Prediction; Prediction models; Prognosis

Year:  2012        PMID: 23493657      PMCID: PMC3596524          DOI: 10.4240/wjgs.v4.i12.281

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  12 in total

1.  Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis.

Authors:  P A Berry; C G Antoniades; M J Hussain; M J W McPhail; W Bernal; D Vergani; J A Wendon
Journal:  Liver Int       Date:  2010-05       Impact factor: 5.828

2.  Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.

Authors:  Charalambos Gustav Antoniades; Philip A Berry; Edward T Davies; Munther Hussain; William Bernal; Diego Vergani; Julia Wendon
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

3.  Utility of the MAYO End-Stage Liver Disease score, King's College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure.

Authors:  M Peláez-Luna; J Martinez-Salgado; M A Olivera-Martinez
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

Review 4.  Acute liver failure.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

5.  Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.

Authors:  A O Shakil; D Kramer; G V Mazariegos; J J Fung; J Rakela
Journal:  Liver Transpl       Date:  2000-03       Impact factor: 5.799

Review 6.  Prediction models in reproductive medicine: a critical appraisal.

Authors:  Esther Leushuis; Jan Willem van der Steeg; Pieternel Steures; Patrick M M Bossuyt; Marinus J C Eijkemans; Fulco van der Veen; Ben W J Mol; Peter G A Hompes
Journal:  Hum Reprod Update       Date:  2009-05-12       Impact factor: 15.610

7.  MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure.

Authors:  Silvina E Yantorno; Walter K Kremers; Andrés E Ruf; Julio J Trentadue; Luis G Podestá; Federico G Villamil
Journal:  Liver Transpl       Date:  2007-06       Impact factor: 5.799

8.  Caspase activation is associated with spontaneous recovery from acute liver failure.

Authors:  Xandra Volkmann; Matthias Anstaett; Johannes Hadem; Penelope Stiefel; Matthias J Bahr; Frank Lehner; Michael P Manns; Klaus Schulze-Osthoff; Heike Bantel
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 9.  Prediction of mortality in very premature infants: a systematic review of prediction models.

Authors:  Stephanie Medlock; Anita C J Ravelli; Pieter Tamminga; Ben W M Mol; Ameen Abu-Hanna
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

Review 10.  Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review.

Authors:  Lilian Minne; Ameen Abu-Hanna; Evert de Jonge
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

View more
  3 in total

Review 1.  Application of mesenchymal stem cell exosomes and their drug-loading systems in acute liver failure.

Authors:  Shuqin Zhang; Yu Hou; Jing Yang; Denghui Xie; Linrui Jiang; Huazhong Hu; Jingjing Hu; Caizhu Luo; Qun Zhang
Journal:  J Cell Mol Med       Date:  2020-06-03       Impact factor: 5.310

2.  STORE-gastrointestinal functions and gastrointestinal hormones in patients with liver failure.

Authors:  Ping Wang; Ying-Jian Zhang; Yi-Ran Li; Xiao-Yan Xia; Shu-Yan Lv
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

3.  A20 rescues hepatocytes from apoptosis through the NF-κB signaling pathway in rats with acute liver failure.

Authors:  Ke-Zhi Li; Zhi-Yi Liao; Yu-Xuan Li; Zhi-Yong Ming; Jian-Hong Zhong; Guo-Bin Wu; Shan Huang; Yin-Ning Zhao
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.